Dr. Patrick Corsino is the Executive Director of Product Development and Technical Operations for IM HealthScience. He is responsible for researching and developing new products for the growing IMH product line in the medical food industry to help keep IMH and its sister companies at the forefront of digestive and brain science. His responsibilities also include coordinating the company’s extensive product manufacturing system. This involves helping manage supply chain processes from raw materials to finished goods and overseeing production of the company’s products at multiple manufacturing facilities.
Dr. Corsino received a bachelor’s degree in Medical Biochemistry from the University of Birmingham in the United Kingdom. Subsequently, he received his PhD and further post-doctoral training from the University of Florida in the department of Pharmacology & Therapeutics, focusing primarily on breast cancer research. Here, he helped identify and develop a novel class of cancer inhibitors, and helped map pathways of interactions between proteins that modulate cell cycle progression.
In 2016, Dr. Corsino was at Nuovo Biologics, a biotechnology company focused on generating novel cancer and antiviral therapeutics, where he worked as the Director of Research & Development. Before that he held the role of laboratory manager at KRS Global Biotechnology, one of the largest compounding pharmacies in the United States. At KRS, he was responsible for overseeing formulation, production and quality control.